Ganz wichtig in fett markiert:
Redfund Capital Corp (CSE:LOAN) says investee firm Biolog Inc is on the "cusp of greatness" as it outlined the progress of the Silicon Valley and LA-based cannabis infusion specialist.
In August, Redfund and Biolog signed a two-year term convertible secured promissory note for $800,000 with an annual interest rate of 14%. Biolog's technology is protected by multiple patents, including a patent portfolio licensed from Lexaria.
This allows the dosing of almost any food or beverage with either cannabidiol (CBD), tetrahydrocannabinol (THC) or any combination of these or other cannabinoids.
"Our licence from Lexaria is what separates Biolog products from all others," said Biolog's chief executive Bruce Bauer.
http://www.proactiveinvestors.co.uk/companies/...reatness-205763.html
|